Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 3,81 % | 0,77 % | -7,96 % | -19,05 % | -23,41 % | - | - |
| Healthequity Inc. | 0,71 % | 0,71 % | 10,94 % | -12,35 % | -8,97 % | 31,48 % | 23,48 % |
| Omnicell Inc. | 0,00 % | -4,76 % | -19,08 % | -12,50 % | -27,84 % | -47,66 % | -74,55 % |
| Myriad Genetics | 0,53 % | -3,57 % | -2,58 % | -53,62 % | -28,68 % | -82,31 % | -85,11 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




